News & Press
Edition 1 / February 2023
Editorial > 2022-2023: A Continuation of Record Growth & Expansion
Edition 1 / February 2023
It is once again my pleasure to welcome you, our customers, partners and suppliers, to the first edition of Corden Connect 2023! This is always a great opportunity for me to keep you updated on the strategies that drive CordenPharma as a leading CDMO for the development and manufacturing of complex modalities for APIs, Lipid Excipients and Drug Products. As a global organization, we continue to transform, develop and stay on top of an ever-changing landscape of industry requirements to serve the most innovative Biotech and Pharma companies, and ultimately contribute to the delivery of critical medicines to their patients. This is what drives us at CordenPharma every day!
I am very proud to report that CordenPharma financially continued its exciting and strong growth trajectory in 2022 by delivering our highest sales to date exceeding >€870M, which represents an increase of ~14% compared to 2021. Despite multiple challenges due to a difficult global environment, this was operationally only possible thanks to our dedicated team of employees across twelve global manufacturing sites in Europe and the US, all supported by a strong site leadership team that exemplified agility, flexibility and fast decision making.
Furthermore, our global operations and engineering teams were very busy in continuing the execution of the large strategic CAPEX projects announced in 2022 to increase development and manufacturing capacity and technology in Peptides, Lipids, Highly Potent and Small Molecules, with the majority of them to be completed in 2023.
As a continuation of these efforts, we made the decision in early 2023 to significantly expand our Peptide manufacturing capacities and capabilities by planning to invest > $60M at our site in Boulder, Colorado, both in mid and large-scale manufacturing, to not only support our fast growing pipeline of new peptide projects, but also the production of a large recently launched innovative product based on a complex Peptide.
In addition, we kicked-off strategic investments at our CordenPharma Caponago Injectable site with the construction of a GMP Lipid NanoParticle (LNP) manufacturing suite (complementing our existing nGMP development capabilities) and the installation of a 3rd aseptic Fill & Finish line. These investments will enable us to uniquely serve our customers from initial Lipid Excipient supply (both standard catalog and innovative, proprietary custom Lipid synthesis) and LNP formulation development of nucleic acids (xRNAs) to final aseptic Fill & Finish from small-scale (clinical trials) to commercial manufacturing. Together with our partner Wacker Biotech, we are able to offer the full supply chain from initial pDNA to mRNA manufacturing as exemplified by the Pandemic Preparedness contract awarded in April 2022 by the German government to both companies.
To complete our capabilities for the manufacturing of complex innovative modalities, I am very excited to announce that we have taken the decision to restart our Oligonucleotide manufacturing in the US at our site in Boulder, Colorado by establishing a Centre of Excellence for Oligonucleotides that will enable the supply of a wide range of synthetic Oligonucleotides to support early clinical to commercial supply to our customers.
On a different note, I want to draw your attention to our announcement at the end of 2022 about joining the Science-Based Targets initiative (SBTi). As a leading CDMO, we have committed to evaluating and developing over the next year science-based greenhouse gas emission reduction targets aligned with the SBTi criteria. Once set, the targets will be submitted to the SBTi partnership for validation and approval, and eventually published on the SBTi website. Environmental, Social & Governance (ESG) is a top priority of both CordenPharma and our new private equity shareholders, Astorg. To this end, we are already working with companies such as EcoVadis on achieving the highest level of sustainability ratings for our global facilities.
Last but not least, thank you to all our customers who have continued to entrust us with their key projects over the years! With all these strategic initiatives across CordenPharma, we continue our aim in better serving our customers and their patients by identifying and expanding on key trends & technologies in the pharmaceutical industry that contribute towards the development of innovative life-saving medications. As stated at the beginning, I can assure you that the CordenPharma team continues to be inspired by the direct impact you (our customers) have on patients, and as such, we strive for excellence every day to deliver on-time, high-quality products with integrity, transparency and flexibility.
As we embark on this new year, we continue to focus growth on our key Technology Platforms – Peptides, Lipids & Carbohydrates, Highly Potent & Oncology, Small Molecules, and Injectables – along with a new Oligonucleotides platform coming soon. In addition, we will strengthen our Fully Integrated Supply Solutions to bring you the maximum benefit for this increased demand.
We look forward to meeting customers in person this year at the upcoming DCAT Week – March 20 – 23 in New York City – and CPHI North America – April 25 – 27 in Philadelphia – or any other planned trade shows to discuss your ongoing & future project needs.
To conclude, feel free to reach out to your respective Key Account Managers to schedule a meeting or provide any feedback on how you believe we can better serve you in the future! We look forward to a successful 2023!
Dr. Michael Quirmbach
President & CEO
CordenPharma Group
Stay up to date with the latest thought leadership articles and news from CordenPharma.
Essential cookies are required for basic website functions. This ensures that the website functions properly
The technical storage or access that is used exclusively for statistical purposes.
Name | _ga |
---|---|
Provider | google-analytics.com |
Purpose | This cookie name is associated with Google Universal Analytics - which is a significant update to Google's more commonly used analytics service. This cookie is used to distinguish unique users by assigning a randomly generated number as a client identifier. It is included in each page request in a site and used to calculate visitor, session and campaign data for the sites analytics reports. |
Cookie life cycle | 2 years |
Name | _gid |
---|---|
Provider | google-analytics.com |
Purpose | This cookie is set by Google Analytics. It stores and update a unique value for each page visited and is used to count and track pageviews. |
Cookie life cycle | 1 Day |
Name | collect |
---|---|
Provider | google-analytics.com |
Purpose | "Used to send data to Google Analytics about the visitor's device and behavior. Tracks the visitor across devices and marketing channels. |
Cookie life cycle | session |
Name | vuid |
---|---|
Provider | vimeo.com |
Purpose | Collects data on the user's visits to the website, such as which pages have been read. These cookies are used by the Vimeo video player on websites. |
Cookie life cycle | 2 years |
Name | BE_CLA3 |
---|---|
Provider | BrightEdge |
Purpose | Enables data aggregation, analysis and report creation to assess marketing effectiveness and for website performance. |
Cookie life cycle | 37199 days |
Name | YSC |
---|---|
Provider | Youtube |
Purpose | This cookie is set by YouTube to track views of embedded videos. |
Cookie life cycle | session |
Name | __utmc |
---|---|
Provider | google-analytics.com |
Purpose | This is one of the four main cookies set by the Google Analytics service which enables website owners to track visitor behaviour and measure site performance. It is not used in most sites but is set to enable interoperability with the older version of Google Analytics code known as Urchin. In this older versions this was used in combination with the __utmb cookie to identify new sessions/visits for returning visitors. When used by Google Analytics this is always a Session cookie which is destroyed when the user closes their browser. Where it is seen as a Persistent cookie it is therefore likely to be a different technology setting the cookie. |
Cookie life cycle | Session |
Name | __utma |
---|---|
Provider | google-analytics.com |
Purpose | This is one of the four main cookies set by the Google Analytics service which enables website owners to track visitor behaviour and measure site performance. This cookie lasts for 2 years by default and distinguishes between users and sessions. It it used to calculate new and returning visitor statistics. The cookie is updated every time data is sent to Google Analytics. The lifespan of the cookie can be customised by website owners. |
Cookie life cycle | 2 years |
Name | __utmz |
---|---|
Provider | google-analytics.com |
Purpose | This is one of the four main cookies set by the Google Analytics service which enables website owners to track visitor behaviour measure of site performance. This cookie identifies the source of traffic to the site - so Google Analytics can tell site owners where visitors came from when arriving on the site. The cookie has a life span of 6 months and is updated every time data is sent to Google Analytics. |
Cookie life cycle | 6 months 2 days |
Name | __utmb |
---|---|
Provider | google-analytics.com |
Purpose | This is one of the four main cookies set by the Google Analytics service which enables website owners to track visitor behaviour measure of site performance. This cookie identifies the source of traffic to the site - so Google Analytics can tell site owners where visitors came from when arriving on the site. The cookie has a life span of 6 months and is updated every time data is sent to Google Analytics. |
Cookie life cycle | 6 months 2 days |
Name | __utmt |
---|---|
Provider | google-analytics.com |
Purpose | This is one of the four main cookies set by the Google Analytics service which enables website owners to track visitor behaviour and measure site performance. This cookie determines new sessions and visits and expires after 30 minutes. The cookie is updated every time data is sent to Google Analytics. Any activity by a user within the 30 minute life span will count as a single visit, even if the user leaves and then returns to the site. A return after 30 minutes will count as a new visit, but a returning visitor. |
Cookie life cycle | 30 minutes |
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Name | visitor_id# |
---|---|
Provider | pardot.com |
Purpose | "Used in context with Account-Based-Marketing (ABM). The cookie registers data such as IP-addresses, time spent on the website and page requests for the visit. This is used for retargeting of multiple users rooting from the same IP addresses. ABM usually facilitates B2B marketing purposes." |
Cookie life cycle | 10 years |
Name | visitor_id#-hash |
---|---|
Provider | pardot.com |
Purpose | Used to encrypt and contain visitor data. This is necessary for the security of the user data. |
Cookie life cycle | 10 years |
Name | Google Maps API |
---|---|
Provider | Google Maps |
Purpose | to read user IP address. |
Cookie life cycle | expires immediately |
Name | GPS |
---|---|
Provider | Youtube |
Purpose | YouTube is a Google owned platform for hosting and sharing videos. YouTube collects user data through videos embedded in websites, which is aggregated with profile data from other Google services in order to display targeted advertising to web visitors across a broad range of their own and other websites. |
Cookie life cycle | session |
Name | PREF |
---|---|
Provider | Youtube |
Purpose | This cookie, which may be set by Google or Doubleclick, may be used by advertising partners to build a profile of interests to show relevant ads on other sites. It works by uniquely identifying your browser and device. |
Cookie life cycle | 8 months |
Name | VISITOR_INFO1_LIVE |
---|---|
Provider | Youtube |
Purpose | This cookie is set by Youtube to keep track of user preferences for Youtube videos embedded in sites;it can also determine whether the website visitor is using the new or old version of the Youtube interface. |
Cookie life cycle | 6 months |